JNCCN

Jump to Content Jump to Main Navigation

CURRENT ISSUE

April 2021 | Volume 19 | Issue 4

IN THIS ISSUE

NCCN Guidelines^® Insights | CE

Melanoma: Cutaneous, Version 2.2021

Original Research

Uptake Rates of Novel Therapies and Survival Among Privately Insured Versus Publicly Insured Patients With Colorectal Cancer in Germany

Original Research

Prognosis of Incidental Brain Metastases in Patients With Advanced Renal Cell Carcinoma

FEATURED CONTENT

NCCN Guidelines^®

Pancreatic Adenocarcinoma, Version 2.2021

Original Research

Medicare/Medicaid Insurance, Rurality, and Black Race Associated With Provision of Hepatocellular Carcinoma Treatment and Survival

Molecular Insights in Patient Care

Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer

Original Research

Performance Status Restriction in Phase III Cancer Clinical Trials

Original Research | ONLINE FIRST

Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy

NCCN Policy Report | ONLINE FIRST

Creative Strategies Implemented During the Coronavirus Pandemic That Will Impact the Future of Cancer Care

JNCCN360

A collection of tumor-specific websites that cover oncology from every angle for the practicing clinician.

Acute Myeloid Leukemia

Chronic Lymphocytic Leukemia

Multiple Myeloma

Non-Melanoma Skin Cancers

Non–Small Cell Lung Cancer

Prostate Cancer

Most Read

What is a Patient Navigator, and Should We Have Them in Major Cancer Centers?

Multiple Myeloma

Novel Therapies in the Treatment of Multiple Myeloma

Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Supportive Therapies in Multiple Myeloma

Most Cited

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors

Second Look: NCCN Guidelines Insights®

Multiple Myeloma, Version 3.2018

Colon Cancer, Version 2.2018

Head and Neck Cancers, Version 1.2018

Thyroid Carcinoma, Version 2.2018

Antiemesis, Version 2.2017